Castle Creek Pharma, a Parsippany, New Jersey and Chicago, Illinois-based biopharmaceutical company developing innovative therapies for patients with rare, serious or debilitating dermatologic conditions, received $71.8m in funding.
European Cannabis Holdings (ECH), a London, UK-based medical cannabis investment group, completed its £3M initial round of funding.
Dragonfly Capital Partners, a San Francisco-based venture capital firm, has launched a $100m fund.
Next Century Spirits, a Raleigh, N.C.-based company that combines traditional distilling techniques and finishing technologies to create enhanced spirits, raised $3.6m in funding.
Tastemade, a Los Angeles, CA-based lifestyle and food digital network and studio, raised $35m in Series E funding.
Postworks, a Northampton, UK-based online franking company providing small and medium sized businesses with a software-based alternative to franked business post, received an investment from Foresight Group LLP.
Alpkit Limited, a Nottingham, UK-based outdoor clothing and equipment retailer, raised £1m in funding.
Alumni Ventures Group, a Manchester, NH-based venture capital fund manager, closed on nearly $30M in capital raised from three of its annual funds.
Future Family, a San Francisco, CA-based fertility care company, raised $10m in Series A funding.
In the United States, the same as in Europe, the number of connected TV users has witnessed a growth of 58% in 2016. By the end of 2021, it will jump up to 21%. Despite the fact that traditional TV viewing time has been declining in all countries, the total consumption of video content is […]
Vector, a Tucson, AZ-based microsatellite launch company, secured an additional $70M in Series B financing.
Invisible, a NYC-based company introducing a new way for people to get work done, raised $2.6M in seed funding.
Kite Hill, a Hayward, CA-based maker of chef-inspired plant-based foods, completed a $40m funding.
TP Therapeutics, a San Diego, CA-based clinical-stage precision oncology company developing novel drugs that address treatment resistance, completed an $80m round of mezzanine financing.
First Round Capital, a US venture capital firm focused on providing seed-stage funding to tech companies, is raising two new funds.